Skip to main content
Overview
Investor Information
Overview
Email Alerts
Share Price
Analyst Coverage
Reports & Filings
Corporate Governance
Shareholder Meetings
Summit Presentations
News
Press Releases
Congresses
Digital Library
Contact
Company
Mission Statement
About Us
Leadership
Board of Directors
Business Development
Contact
Pipeline
Ivonescimab (SMT112)*
Ivonescimab Overview
Akeso Partnership
Lung Cancer Overview
Clinical Trials
Clinical Trials Overview
HARMONi Clinical Trial
HARMONi-3 Clinical Trial
HARMONi-7 Clinical Trial
HARMONi-GI3 Clinical Study
IST Program
Early Access
Med Info Request
Publications
U.S. Patients & Caregivers
Patients & Caregivers
HARMONi-3 Clinical Trial
HARMONi-7 Clinical Trial
Med Info Request
Careers
Careers Overview
Current Openings
Overview
Investor Information
Overview
Email Alerts
Share Price
Analyst Coverage
Reports & Filings
Corporate Governance
Shareholder Meetings
Summit Presentations
News
Press Releases
Congresses
Digital Library
Contact
Company
Mission Statement
About Us
Leadership
Board of Directors
Business Development
Contact
Pipeline
Ivonescimab (SMT112)*
Ivonescimab Overview
Akeso Partnership
Lung Cancer Overview
Clinical Trials
Clinical Trials Overview
HARMONi Clinical Trial
HARMONi-3 Clinical Trial
HARMONi-7 Clinical Trial
HARMONi-GI3 Clinical Study
IST Program
Early Access
Med Info Request
Publications
U.S. Patients & Caregivers
Patients & Caregivers
HARMONi-3 Clinical Trial
HARMONi-7 Clinical Trial
Med Info Request
Careers
Careers Overview
Current Openings
Skip to main content
Event Details
Summit Therapeutics Q2 2024 Earnings Call
August 6, 2024 9:00 AM ET
Webcast
(opens in new window)